Fintel reports that on April 9, 2025, HC Wainwright & Co. initiated coverage of Bionano Genomics (NasdaqCM:BNGO) with a Buy recommendation. Analyst Price Forecast Suggests 2,062.54% Upside As of April ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS – Research Report) and BioNano Genomics ...

BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-60. The effective time of the reverse stock split ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano Genomics is eagerly anticipated, with investors seeking news of surpassing ...

Bionano Genomics (BNGO) announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of multiple ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bionano Genomics wasn’t one of them. The 10 stocks that made ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...